Evidence map›Paper›PMID 37910336›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2023

Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.

Hugo M Aarts, Nicole D van Hemert, Timion A Meijs, Astrid C van Nieuwkerk, Jurriën M Ten Berg, Joanna J Wykrzykowska, Niels van Royen, Carl E Schotborgh, Pim A L Tonino, Alexander IJsselmuiden and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  5. Article
  6. Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Enhancing dialogue: Introducing 'Letters to the Editor'.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
  14. Reply to 'Percutaneous coronary intervention timing and coronary physiology in transcatheter aortic valve implantation patients'.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
  15. Percutaneous coronary intervention timing and coronary physiology in transcatheter aortic valve implantation patients.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Article
  16. Article
  17. The future of transcatheter aortic valve implantation is bright.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Hugo M AartsDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Nicole D van HemertDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Timion A MeijsDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Astrid C van NieuwkerkDepartment of Cardiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Jurriën M Ten BergDepartment of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Joanna J WykrzykowskaDepartment of Cardiology, Groningen University Medical Centre, University of Groningen, Groningen, The Netherlands.
Niels van RoyenDepartment of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Carl E SchotborghDepartment of Cardiology, Haga Hospital, The Hague, The Netherlands.
Pim A L ToninoDepartment of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
Alexander IJsselmuidenDepartment of Cardiology, Amphia Hospital, Breda, The Netherlands.
Tessel N VossenbergDepartment of Cardiology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Gert K van HouwelingenDepartment of Cardiology, Thorax Centre Twente, Medical Spectrum Twente, Enschede, The Netherlands.
Ton SlagboomDepartment of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Michiel VoskuilDepartment of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ronak DelewiDepartment of Cardiology, Amsterdam University Medical Centre, Amsterdam, The Netherlands. r.delewi@amsterdamumc.nl.ORCID http://orcid.org/0000-0001-6070-9423
University Medical Center Utrecht · NLRadboud University Nijmegen · NLAmphia Ziekenhuis · NLAmsterdam University Medical Centers · NLHaga Hospital · NLMaastricht University Medical Centre · NLMedisch Centrum Leeuwarden · NLMedisch Spectrum Twente · NLOLVG · NLUniversity Medical Center Groningen · NL

Funding

ZonMw 852002124
6 · The paper itself

Abstract

objectiveThe importance of revascularisation of significant coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) is unclear. Despite the lack of randomised controlled trials comparing different revascularisation strategies, guidelines currently recommend percutaneous coronary intervention (PCI) in patients with significant proximal CAD undergoing TAVI.

methodsIn this systematic review and meta-analysis, a systematic search was conducted to identify studies comparing TAVI with and without PCI in patients with significant CAD on pre-TAVI coronary angiography. Endpoints were all-cause mortality, cardiac death, stroke, myocardial infarction and major bleeding.

resultsIn total, 14 studies were included, involving 3838 patients, of whom 1806 (47%) underwent PCI before TAVI. All-cause mortality did not differ significantly between TAVI with and without preceding PCI at 30 days, 1 year and > 1 year. There were no significant differences in risk of cardiac death, stroke or myocardial infarction between the groups. However, TAVI performed with PCI resulted in a higher risk of major bleeding within 30 days after TAVI (odds ratio: 0.66; 95% confidence interval: 0.46-0.94).

conclusionThis systematic review and meta-analysis showed no significant differences in clinical outcomes between patients with concomitant significant CAD who were treated with TAVI with and without preceding PCI at both short- and long-term follow-up. However, there was a higher risk of major bleeding at 30 days in patients undergoing TAVI with preceding PCI. In the context of serious risk of bias in the included studies, results of randomised controlled trials are warranted.

Indexed as

Aortic Valve StenosisCoronary Artery DiseasePercutaneous Coronary InterventionTranscatheter Aortic Valve Implantation

Identifiers

PMID37910336
PMCPMC10667197
OpenAlexW4388140786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.